MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Bihar, India)

    Objective: The present study examined the potential therapeutic effects of CA against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored…
  • 2018 International Congress

    Motor and Non-motor Features Predict Freezing of Gait in Parkinson’s Disease

    N. D'Cruz, G. Vervoort, S. Fieuws, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: To investigate and evaluate behavioral predictors of conversion to Freezing of Gait in Parkinson’s Disease (PD). Background: Freezing of Gait (FOG) has devastating consequences…
  • 2018 International Congress

    Relationship of 10-Meter Walk Test to balance performance in Parkinson’s disease patients as a predictor of falls

    A.P.C. Loureiro, B. Yamaguchi, V. Israel (Curitiba, Brazil)

    Objective: This study aimed to clarify the relationship between the 10-Meter Walk Test (10-MWT) and balance performance in PD. Background: Patients with Parkinson's disease (PD)…
  • 2018 International Congress

    Assessing the potential cost-effectiveness of ads-5102 (Amantadine HCl) for the treatment of dyskinesia in Parkinson’s disease patients

    R. Pahwa, L. Garrison, M. Zimmerman, R. Johnson, J. Nguyen, M. Li, R. Patni (Kansas City, KS, USA)

    Objective: This economic evaluation projects the likely cost-effectiveness of ADS-5102 in comparison to the current standard of best supportive care. Background: In August, 2017, the…
  • 2018 International Congress

    Exploring The Role of a Prescribing Pharmacist in the Management of Parkinson’s Disease

    E. Wong (London, United Kingdom)

    Objective: Aims/Objectives A review to explore the role of a pharmacist NMP within the neurology PD multidisciplinary team during a six month period between 1st…
  • 2018 International Congress

    Home Care Programme for Patients with Parkinsonism

    WL. Chan, ST. Chua, W. Li, HL. Ng, KY. Tay, WL. Au, CS. Tan (Singapore, Singapore)

    Objective: To review patients and caregivers’ feedback on the service for the period from mid Oct 2015 to June 2017 as part of quality improvement…
  • 2018 International Congress

    Characterizing the spectrum of Non-motor Symptoms in Progressive Supranuclear Palsy

    C. S P, V. Holla, S. Prasad, A. Stezin, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To systematically assess the specific Non-motor symptoms in Progressive Supranuclear Palsy using the Non Motor Symptom assessment scale (NMSS). Background: Progressive supranuclear palsy (PSP)…
  • 2018 International Congress

    Toxin-induced Parkinsonism: A report of two patients

    Z. Aldaajani (Dhahran, Saudi Arabia)

    Objective: To highlight the presentation of parkinsonism caused by acute and chronic exposure to carbon monoxide(CO). Background: Toxin-induced parkinsonism is not uncommon. One of the…
  • 2018 International Congress

    Postural deformities in Chinese patients with multiple system atrophy

    L. Zhang, B. Cao, Y. Zou, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shanng (Chengdu, China)

    Objective: The objective of our study was to investigate the frequency and clinical characteristics of the postural deformities in Chinese patients with multiple system atrophy…
  • 2018 International Congress

    Unusual prolonged survival in multiple system atrophy: A case report

    DM. Giraldo, A. Garrido, C. Simonet, J. Saavedra, Y. Compta, M. Marti, E. Tolosa, F. Valldeoriola (Barcelona, Spain)

    Objective: To present a case of a patient with multiple system atrophy (MSA) parkinsonian subtype (MSA-P) with unusual long disease duration. Background: MSA is a…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley